Top Trends Driving Innovation and Change in the Cancer Supportive Care Products Market: Advancements In Cancer Supportive Care With The Rise Of Targeted Radioligand Therapy (RLT)
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Cancer Supportive Care Products Market Size From 2025 to 2034?
The market size of cancer supportive care products has seen a consistent increase over the past few years. From $21.56 billion in 2024, it’s predicted to reach a market value of $22.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.2%. Factors contributing to this growth during the historic period include a rise in cancer cases, improved knowledge and education, enhancement in healthcare facilities, a rising aging population, heightened awareness, and early diagnosis.
The market for cancer supportive care products is predicted to experience consistent growth in the coming years, reaching a value of $27.01 billion in 2029 with a compound annual growth rate (CAGR) of 4.7%. The potential growth during the forecast period is ascribed to factors such as increasing cancer incidences, the surge in patient-focused treatments, expanded investment in cancer studies, an escalated emphasis on personalized medication, and a rise in cancer survival rates. Significant trends expected over the forecast period encompass technological advancements in the field, sophisticated drug delivery methods, novel drug formulations, individualized patient care, and the emergence of biodegradable products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18529&type=smp
What External and Internal Drivers Are Contributing to the Growth of theCancer Supportive Care Products Market?
The surge in cancer cases is predicted to stimulate the expansion of the cancer supportive care products market. The aging population is at a higher risk for developing cancer due to cellular changes and extended exposure to risk factors. Contributing factors such as smoking, unhealthy diet, absence of physical exercise, and excessive alcohol intake significantly increase the risk of cancer. Cancer supportive care products are essential in managing symptoms, enhancing life quality, and offering support to patients under treatment, meeting the rising demand prompted by the escalating cancer rates. For example, the American Cancer Society, a US-based nonprofit committed to eradicating cancer, predicted in January 2024 that the cases of oral cavity and pharynx cancer would rise to 58,450, marking a 7.2% increase from the 54,540 cases recorded in 2023. As such, the escalating incidence of cancer is expected to fuel the growth of the cancer supportive care products market.
What Segment Types Define the Cancer Supportive Care Products Market Structure?
The cancer supportive care productsmarket covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor
2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies
Subsegments
1) By Nonsteroidal Anti-Inflammatory Drugs (Nsaids): Ibuprofen, Aspirin, Naproxen
2) By Anti-Infective: Antibiotics, Antifungal Drugs, Antiviral Drugs
3) By Anti-Emetics: 5-Ht3 Antagonists (Ondansetron), Nk1 Antagonists (Aprepitant), Corticosteroids (Dexamethasone)
4) By Monoclonal Antibodies: Rituximab, Trastuzumab, Bevacizumab
5) By Erythropoietin Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa
6) By Opioid Analgesics: Morphine, Fentanyl, Oxycodone
7) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate
8) By Granulocyte Colony Stimulating Factor: Filgrastim, Pegfilgrastim
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18529&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Cancer Supportive Care Products Market?
North America was the largest region in the cancer supportive care products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Cancer Supportive Care Products Market?
Leading businesses in the cancer supportive care products market are prioritizing the progression of cancer treatments, like targeted radioligand therapy (RLT), with the goal of increasing treatment effectiveness, lowering side effects, and enhancing patient outcomes. A targeted RLT platform incorporates radiolabeled molecules that attach specifically to markers on cancer cells, thereby delivering precise radiation and selectively eliminating cancer cells while preserving healthy tissue. For instance, Novartis AG, a pharmaceutical corporation based in Switzerland, was granted approval by the US Food and Drug Administration (FDA) in May 2022 for the use of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in the treatment of adult patients suffering from prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that has continued to metastasize in spite of previous treatments. Pluvicto is the inaugural FDA-approved targeted RLT for qualifying mCRPC patients, bringing together a target ligand with a therapeutic radioisotope. The FDA has also approved the use of Locametz (gallium Ga 68 gozetotide injection), utilized in PET scans to identify PSMA-positive lesions, which assists in locating the spread of cancer and determining suitability for Pluvicto therapy.
View the full report here:
What Is the Definition of the Cancer Supportive Care Products Market?
Cancer supportive care products refer to a range of medical treatments, therapies, and products designed to manage and alleviate the symptoms, side effects, and complications associated with cancer and its treatments. These products aim to improve the quality of life for cancer patients by addressing various aspects of care, including physical, emotional, and psychological support.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18529
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
